Fengjie Guo
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
ANLN: A New Hub in Glutamine Metabolism of Lung Adenocarcinoma by scRNA-Seq and Machine Learning.
Journal: Oncology research
Published: January 22, 2026
PIK3C2B drives lung cancer progression through coordinating metabolic reprogramming and EMT-mediated metastasis.
Journal: Biochemistry and biophysics reports
Published: April 08, 2025
Qili Qiangxin ameliorates chronic heart failure: a randomized clinical trial of biomarkers, inflammation, and cardiac outcomes.
Journal: Frontiers in pharmacology
Published: April 04, 2025
Exploring the oncogenic potential of Aiolos in lung cancer through OTUB1-mediated ubiquitination.
Journal: Heliyon
Published: June 09, 2024
Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression.
Journal: Genes & diseases
Published: August 05, 2023
Integrative analysis of single-cell and bulk RNA-sequencing data revealed T cell marker genes based molecular sub-types and a prognostic signature in lung adenocarcinoma.
Journal: Scientific reports
Published: April 28, 2023
Aptamer-siRNA chimera and gold nanoparticle modified collagen membrane for the treatment of malignant pleural effusion.
Journal: Frontiers in bioengineering and biotechnology
Published: June 20, 2022
The Inhibitory Effect of Regulatory T Cells on the Intimal Hyperplasia of Tissue-Engineered Blood Vessels in Diabetic Pigs.
Journal: Frontiers in bioengineering and biotechnology
Published: April 27, 2022
MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
Journal: Thoracic cancer
Published: November 07, 2021
Prognostic and immunological significance of metastasis associated lung adenocarcinoma transcript 1 among different kinds of cancers.
Journal: Bioengineered
Published: July 26, 2021
Last Updated: 09/26/2026